HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a large growth in short interest during the month of December. As of December 15th, there was short interest totalling 6,500 shares, a growth of 170.8% from the November 30th total of 2,400 shares. Based on an average daily volume of 11,300 shares, the days-to-cover ratio is currently 0.6 days.
HAVN Life Sciences Price Performance
HAVLF traded up $0.02 on Thursday, hitting $0.06. 6,005 shares of the company were exchanged, compared to its average volume of 5,798. The firm has a fifty day simple moving average of $0.06 and a two-hundred day simple moving average of $0.50. HAVN Life Sciences has a 12 month low of $0.04 and a 12 month high of $4.59.
Get
HAVN Life Sciences alerts:
About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.
Featured Stories
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- Cal-Maine Posts Record Quarter, Remain CALM Income Investors
- Tesla Stock: What the Bulls and the Bears Are Getting Wrong
- Big Health Care Stocks to Watch in the New Year
- The Top Three Stocks Analysts Say To Buy
- Can Dick's Sporting Goods Stock Score Another Win In Q4?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
HAvn Life Science Inc.(場外交易市場代碼:HAVLF-GET Rating)是空頭股數12月份實現大幅增長的接受者。截至15日,空頭股數共有6,500股,較11月30日的2,400股增長170.8。以日均成交量11,300股計算,目前天數與回補比率為0.6天。
擁有生命科學的性價比
HAVLF週四上漲0.02美元,觸及0.06美元。該公司股票成交量為6,005股,而其平均成交量為5,798股。該公司的50日簡單移動均線切入位為0.06美元,200日簡單移動均線切入位為0.50美元。HAvn Life Sciences的12個月低點為0.04美元,12個月高位為4.59美元。
到達
擁有生命科學學位警報:
關於HAVN生命科學
(獲取評級)
HAVN生命科學公司是一家生物技術公司,從事從植物和真菌中提取的精神藥理產品的研究和開發。該公司還專注於開發從植物和真菌(包括裸子菌屬)中標準化和質量控制地提取精神活性化合物的方法。
專題報道
- 免費獲取StockNews.com關於HAVN生命科學的研究報告(HAVLF)
- 加州緬因州公佈創紀錄的季度業績,保持冷靜的收入投資者
- 特斯拉股票:公牛和熊隊哪裡出了問題
- 新年值得關注的大型醫療保健類股
- 分析師認為最值得買入的三隻股票
- Dick‘s Sports Goods Stock能否在第四季度再獲勝利?
接受《HAVN生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對HAVN生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。